Amaro
Novel taste receptor therapeutics for metabolic disease
New York, United States · Founded 2021
- Headquarters
- New York
- Employees
- 1–10
- Founded
- 2021
- Business Model
- B2B
- Website
- amarotx.com
- Last Round
- SeedJan 2019
- Rounds
- 1
About
Amaro Therapeutics is a clinical-stage biotech company founded in 2021 and based in New York. The company develops first-in-class small molecule therapeutics targeting bitter taste receptors (TAS2R) for the treatment of metabolic and immunologic diseases. Amaro's proprietary platform leverages a novel understanding of TAS2R biology to create oral, tissue-selective medicines addressing significant patient unmet needs in obesity, diabetes, and immune-mediated conditions.
Summary
Amaro is an Adtech company based in New York, United States, founded in 2021. Its most recent funding was a Seed round in Jan 2019.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jan 2019
Similar Companies
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic develops reliable, interpretable, and steerable AI systems, translating frontier safety...
xAI builds AI systems, including Grok, with frontier reasoning, voice, and generative media capab...
Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...
Databricks provides a unified data and AI platform that helps enterprises build and run applicati...
AI company focused on applying artificial intelligence to physical tasks, launched with $6.2B ini...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/amaro"><img src="https://indexed.vc/api/badge/company/amaro" alt="Amaro on Indexed.vc" width="260" height="76" /></a>